TVTX

Travere Therapeutics, Inc. Common Stock

49.97

USD

-0.11

-0.22%

Oct 26, 15:59 UTC -4

Closed

Pre-Market

50.00

+0.03

+0.06%

Travere Therapeutics, Inc. Common Stock (TVTX) Earnings

TVTX Earnings Reports

Positive Surprise Ratio

TVTX beat 18 of 43 last estimates.

42%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Travere Therapeutics, Inc. Common Stock earnings per share and revenue

On Oct 22, 2026, TVTX reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of 0.06 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 202.29 million, with a --% difference.

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

argenx SE - ADR

Report Date

Oct 22, 2026 For Q3 26

Estimate

$8.19

Actual

$7.80

Surprise

-4.84%

QIAGEN N.V.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.63

Actual

$0.65

Surprise

+2.43%

Acumen Pharmaceuticals, Inc. Common Stock

Report Date

Oct 26, 2026 For Q3 26

Estimate

-$0.39

Actual

-$0.35

Surprise

+11.79%

Tiziana Life Sciences Ltd. Common Shares

Report Date

Oct 16, 2026 For Q2 26

Estimate

-$0.08

Actual

-$0.10

Surprise

-22.55%

FAQ

What were Travere Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Travere Therapeutics, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Travere Therapeutics, Inc. Common Stock's Q3 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Travere Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Travere Therapeutics, Inc. Common Stock's next earnings report?

Based on -- analysts, Travere Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.